Article
[The results of treating fibrous-cavernous tuberculosis in patients with different genetic markers].
Terapevticheskii arkhiv - 1 Jan 1990
Khomenko A G, Sadykov A S
Abstract excerpt
Overall 221 patients with fibrous-cavernous tuberculosis were examined. In patients carrying Hp 2-2 haptoglobin and HLA DR2, the disease runs an unfavourable course more frequently. Among the patients with Hp 2-2, the positive dynamics was attained by the 6th month of the treatment in 44.1%, amon...
Topics
- Adult
- Aged
- Antitubercular Agents
- Chronic Disease
- Drug Evaluation
- Female
- Genetic Markers
- Genetic Predisposition to Disease
- HLA-DR Antigens
- Haptoglobins
- Humans
- Male
- Middle Aged
- Phenotype
- Tuberculosis, Pulmonary